CD44 and breast carcinoma: While FAP-a-expressing active fibroblasts promote breast tumorigenesis and are implicated in an immunosuppressive environment [29], CD10+ GPR77+ as well as CD44+ active breast fibroblasts promote breast cancer stemness and chemoresistance [11,24,30].